Laboratorios Farmaceúticos Rovi SA

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: ES0157261019
EUR
62.25
0.4 (0.65%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
763.75
829.51
817.70
648.68
419.96
381.31
303.20
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
763.75
829.51
817.70
648.68
419.96
381.31
303.20
Raw Material Cost
314.07
365.42
320.96
285.22
198.25
184.82
210.84
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
135.66
122.81
106.52
89.80
74.43
72.51
70.18
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
2.35
0.95
0.85
0.91
1.07
0.93
0.71
Selling and Distribution Expenses
236.25
213.93
213.84
148.57
113.90
120.30
41.77
Other Expenses
-11.23
-9.88
-8.35
-6.33
-5.17
-4.41
-3.85
Total Expenditure (Excl Depreciation)
576.07
604.27
558.66
461.24
335.95
334.43
284.98
Operating Profit (PBDIT) excl Other Income
187.7
225.2
259
187.39999999999998
84
46.900000000000006
18.2
Other Income
1.48
1.98
4.89
2.38
1.20
1.15
1.50
Operating Profit (PBDIT)
208.20
245.78
281.50
205.48
98.40
61.40
29.41
Interest
2.35
0.95
0.85
0.91
1.07
0.93
0.71
Exceptional Items
0.00
0.03
-0.01
-0.77
-5.13
-0.18
0.00
Gross Profit (PBDT)
449.68
464.09
496.74
363.46
221.72
196.49
92.37
Depreciation
28.02
24.33
22.87
21.36
19.59
18.22
12.04
Profit Before Tax
177.83
220.53
257.77
182.45
72.61
42.08
16.66
Tax
40.81
50.11
58.30
29.55
11.52
2.61
-1.22
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
136.88
170.34
199.67
153.08
61.06
39.27
17.89
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
136.88
170.34
199.67
153.08
61.06
39.27
17.89
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.01
-0.04
-0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
136.88
170.30
199.66
153.08
61.06
39.27
17.89
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.06
0.06
0.06
0.06
0.06
0.06
0.06
Reserves
572.03
539.39
520.01
470.98
373.70
322.39
287.47
Earnings per share (EPS)
2.68
3.29
3.73
2.76
1.1
0.71
0.35
Diluted Earnings per share
2.68
3.29
3.73
2.76
1.1
0.71
0.35
Operating Profit Margin (Excl OI)
23.4%
26.46%
31.03%
28.02%
18.48%
11.02%
5.23%
Gross Profit Margin
26.95%
29.52%
34.32%
31.42%
21.96%
15.81%
9.47%
PAT Margin
17.92%
20.53%
24.42%
23.6%
14.54%
10.3%
5.9%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is -7.93% vs 1.44% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is -19.61% vs -14.72% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is -15.22% vs -11.86% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 166.67% vs 12.50% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has fallen from Dec 2023

Compare Annual Results Of Laboratorios Farmaceúticos Rovi SA With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(EUR)
Change(%)
Net Sales
763.75
7,212.38
-6,448.63
-89.41%
Other Operating Income
0.00
0.00
0.00
Total Operating income
763.75
7,212.38
-6,448.63
-89.41%
Raw Material Cost
314.07
4,582.44
-4,268.37
-93.15%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
135.66
2,052.69
-1,917.03
-93.39%
Power Cost
0
0
0.00
Manufacturing Expenses
2.35
714.76
-712.41
-99.67%
Selling and Distribution Expenses
236.25
1,144.01
-907.76
-79.35%
Other Expenses
-11.23
-243.67
232.44
95.39%
Total Expenditure (Excl Depreciation)
576.07
6,057.17
-5,481.10
-90.49%
Operating Profit (PBDIT) excl Other Income
187.68
1,155.21
-967.53
-83.75%
Other Income
1.48
-13.27
14.75
111.15%
Operating Profit (PBDIT)
208.20
1,549.05
-1,340.85
-86.56%
Interest
2.35
714.76
-712.41
-99.67%
Exceptional Items
0.00
10.80
-10.80
-100.00%
Gross Profit (PBDT)
449.68
2,629.95
-2,180.27
-82.90%
Depreciation
28.02
437.90
-409.88
-93.60%
Profit Before Tax
177.83
407.19
-229.36
-56.33%
Tax
40.81
231.19
-190.38
-82.35%
Provisions and contingencies
0
0
0.00
Profit After Tax
136.88
156.92
-20.04
-12.77%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
136.88
156.92
-20.04
-12.77%
Share in Profit of Associates
0
0
0.00
Minority Interest
-0.01
55.89
-55.90
-100.02%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
136.88
212.81
-75.93
-35.68%
Equity Capital
0
0
0.00
Face Value
0.06
0.25
0.00
Reserves
572.03
5,883.73
-5,311.70
-90.28%
Earnings per share (EPS)
2.68
0.23
2.45
1,065.22%
Diluted Earnings per share
2.68
0.23
2.45
1,065.22%
Operating Profit Margin (Excl OI)
23.40%
15.59%
0.00
7.81%
Gross Profit Margin
26.95%
11.72%
0.00
15.23%
PAT Margin
17.92%
2.18%
0.00
15.74%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 76.37 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -7.93% vs 1.44% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 13.69 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -19.61% vs -14.72% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 20.67 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -15.22% vs -11.86% in Dec 2023

Annual - Interest
Interest 0.24 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 166.67% vs 12.50% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 23.40%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has fallen from Dec 2023